Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening....

Descripción completa

Detalles Bibliográficos
Autores principales: Falender, Rebecca A., Mitchell, Paul G., Guzman-Cottrill, Judith A., Cieslak, Paul R., Sutton, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852/
https://www.ncbi.nlm.nih.gov/pubmed/37486347
http://dx.doi.org/10.3201/eid2908.230471
_version_ 1785078026512367616
author Falender, Rebecca A.
Mitchell, Paul G.
Guzman-Cottrill, Judith A.
Cieslak, Paul R.
Sutton, Melissa
author_facet Falender, Rebecca A.
Mitchell, Paul G.
Guzman-Cottrill, Judith A.
Cieslak, Paul R.
Sutton, Melissa
author_sort Falender, Rebecca A.
collection PubMed
description We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence.
format Online
Article
Text
id pubmed-10370852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-103708522023-08-01 Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 Falender, Rebecca A. Mitchell, Paul G. Guzman-Cottrill, Judith A. Cieslak, Paul R. Sutton, Melissa Emerg Infect Dis Dispatch We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence. Centers for Disease Control and Prevention 2023-08 /pmc/articles/PMC10370852/ /pubmed/37486347 http://dx.doi.org/10.3201/eid2908.230471 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Falender, Rebecca A.
Mitchell, Paul G.
Guzman-Cottrill, Judith A.
Cieslak, Paul R.
Sutton, Melissa
Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title_full Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title_fullStr Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title_full_unstemmed Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title_short Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
title_sort pediatric sars-cov-2 seroprevalence, oregon, usa, november 1, 2020–june 30, 2022
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852/
https://www.ncbi.nlm.nih.gov/pubmed/37486347
http://dx.doi.org/10.3201/eid2908.230471
work_keys_str_mv AT falenderrebeccaa pediatricsarscov2seroprevalenceoregonusanovember12020june302022
AT mitchellpaulg pediatricsarscov2seroprevalenceoregonusanovember12020june302022
AT guzmancottrilljuditha pediatricsarscov2seroprevalenceoregonusanovember12020june302022
AT cieslakpaulr pediatricsarscov2seroprevalenceoregonusanovember12020june302022
AT suttonmelissa pediatricsarscov2seroprevalenceoregonusanovember12020june302022

Ejemplares similares